An EEG test — short for electroencephalogram — is one of the most important diagnostic tools in neurology, measuring the brain's electrical activity through electrodes placed on or inside the skull. While the standard scalp-based EEG test is painless and widely available, a subset of patients with drug-resistant epilepsy or complex brain conditions require a far more detailed form of monitoring known as invasive EEG. This procedure places electrodes directly on or within brain tissue to capture signals that scalp electrodes simply cannot detect through the layers of skull and skin.
An EEG test — short for electroencephalogram — is one of the most important diagnostic tools in neurology, measuring the brain's electrical activity through electrodes placed on or inside the skull. While the standard scalp-based EEG test is painless and widely available, a subset of patients with drug-resistant epilepsy or complex brain conditions require a far more detailed form of monitoring known as invasive EEG. This procedure places electrodes directly on or within brain tissue to capture signals that scalp electrodes simply cannot detect through the layers of skull and skin.
Understanding what an EEG medical test involves — and specifically how invasive EEG differs from the standard version — is essential for patients preparing for epilepsy surgery evaluations, for families supporting loved ones through a pre-surgical workup, and for EEG technologists and neurophysiology professionals studying for board certification. The stakes are high: invasive EEG is typically the last step before a surgeon removes the brain tissue responsible for causing seizures, so the accuracy of the data it captures can determine a patient's quality of life for decades to come.
The EEG test cost and logistical demands of invasive monitoring are substantial. Patients undergoing this procedure are admitted to a hospital epilepsy monitoring unit (EMU) for anywhere from three days to two or three weeks, with continuous video-EEG recording capturing every seizure as it occurs. Unlike a routine outpatient EEG test — which typically lasts 20 to 40 minutes and costs between $200 and $700 depending on insurance — invasive EEG involves neurosurgery, an inpatient stay, and a multidisciplinary team of epileptologists, neurosurgeons, neuropsychologists, and EEG technologists working in close collaboration.
There are two primary types of invasive EEG used in US epilepsy centers today: subdural grid and strip electrode monitoring, and stereoelectroencephalography, known as SEEG. Each method places electrodes in different configurations and is selected based on the suspected location of the seizure focus, the patient's anatomy, and the specific clinical questions the team needs to answer before surgery. The choice between these approaches has shifted significantly over the past decade, with SEEG becoming increasingly dominant at major academic centers due to its minimally invasive profile and ability to sample deep brain structures.
From a patient perspective, the question of how long an EEG test takes becomes far more complex in the invasive setting. Rather than the brief 20-to-40-minute window of a routine outpatient study, invasive EEG monitoring can span one to three weeks. The goal is to capture a sufficient number of spontaneous seizures — typically at least three to five representative events — to reliably map the seizure-onset zone and delineate it from eloquent cortex responsible for language, movement, and memory.
EEG test side effects in the invasive setting are considerably more significant than those associated with standard scalp EEG, which carries virtually no risks beyond mild scalp irritation from electrode paste. Invasive electrode placement requires a surgical procedure under general anesthesia, carrying risks of bleeding, infection, neurological deficits, and in rare cases, more serious complications. Patients and families must weigh these procedural risks against the potential benefit of achieving seizure freedom through surgery — a life-changing outcome for approximately 60 to 70 percent of carefully selected candidates.
This comprehensive guide explains what an invasive EEG test is, how the procedure works step by step, what patients can expect before, during, and after monitoring, how to interpret the information it provides, and how this knowledge applies to EEG technologist board exams. Whether you are a patient preparing for a pre-surgical workup or a neurophysiology professional building your clinical knowledge base, understanding invasive EEG is foundational to grasping the full spectrum of what the EEG test can reveal about the human brain.
Platinum or stainless-steel contacts embedded in a silastic sheet and placed directly on the brain's cortical surface via craniotomy. Grids provide excellent spatial coverage of the cortical surface and are ideal for mapping eloquent cortex through cortical stimulation mapping before resection.
Narrower, flexible electrode arrays placed through small burr holes rather than a full craniotomy. Strips can be inserted to reach the interhemispheric fissure, basal temporal lobe, and other cortical surfaces that grids cannot easily access due to their rigid shape.
Thin, cylindrical electrodes implanted stereotactically through multiple small drill holes in the skull. SEEG reaches deep structures — hippocampus, amygdala, insula, cingulate cortex — with minimal brain retraction and lower surgical risk compared to open craniotomy approaches.
Semi-invasive electrodes passed through the foramen ovale at the skull base to record from mesial temporal structures. Used at some centers as an intermediate step between scalp EEG and full intracranial monitoring for suspected temporal lobe epilepsy.
The invasive EEG process begins weeks before any electrode is placed, with a comprehensive pre-surgical evaluation designed to identify each patient's seizure-onset zone and determine whether surgery is feasible. This evaluation typically includes high-resolution MRI of the brain, prolonged scalp video-EEG recording to capture multiple seizures, functional imaging such as PET or ictal SPECT scans, and a detailed neuropsychological battery. The entire team meets at a multidisciplinary conference to review all data and formulate a hypothesis about where seizures are beginning — and only then is an invasive EEG strategy designed.
Once the decision to proceed with invasive monitoring is made, the neurosurgeon and epileptologist collaborate to design an electrode implantation plan. For SEEG, this involves sophisticated 3D brain mapping using MRI and CT imaging fused together to identify safe trajectories for each electrode — paths that avoid major blood vessels while reaching the target brain structures. Modern centers use robotic stereotactic systems such as the ROSA robot to place SEEG electrodes with submillimeter accuracy, reducing both surgical time and procedural risk compared to traditional frame-based techniques.
On the day of electrode implantation surgery, the patient receives general anesthesia. For SEEG, the procedure typically takes two to four hours depending on the number of electrodes placed — most evaluations use between 8 and 18 depth electrodes, though some complex cases may require more. For subdural grid placement, the surgery involves a craniotomy, meaning a section of the skull is temporarily removed to allow the surgeon to lay electrodes directly on the brain surface. This more extensive operation typically takes three to five hours and requires a brief intensive care unit stay afterward.
After surgery, patients are transferred to the epilepsy monitoring unit, where continuous video-EEG recording begins. Anti-seizure medications are often tapered or discontinued to allow seizures to occur more frequently so the team can capture sufficient data. EEG technologists play a critical role during this phase, monitoring recordings around the clock, marking seizure events, adjusting electrode impedances, and ensuring signal quality remains high throughout the monitoring period. Understanding electrode artifact versus true epileptiform activity is a core competency tested on the ABRET R.EEG.T. examination.
During the monitoring period, the epileptologist reviews recordings daily, identifying the electrodes that show the earliest, most consistent seizure onset activity. Additional analyses — including high-frequency oscillation detection, electrical stimulation mapping, and functional connectivity analysis — help refine the map of both the seizure-onset zone and the eloquent cortex that must be preserved during resection. The precision of this mapping is what distinguishes invasive EEG from all other diagnostic tools: it provides information about brain function at a millimeter scale that no imaging modality can match.
When sufficient seizure data has been collected and cortical mapping is complete, the electrodes are removed in a second, shorter surgical procedure. For SEEG, removal requires only light sedation in most cases, as the thin electrodes are simply withdrawn through the same drill holes. Grid and strip removal typically requires returning to the operating room under general anesthesia. Following electrode removal, the epilepsy team reconvenes to finalize the surgical plan, and if the patient, family, and team agree that resection is appropriate, the definitive surgery is typically scheduled within days to weeks.
The entire sequence — from initial evaluation through invasive monitoring to resection — can span three to six months at many centers. However, the investment of time is justified by outcomes: patients who achieve seizure freedom after surgery guided by invasive EEG report dramatic improvements in quality of life, employment, independence, and mood. For EEG professionals and students, understanding each phase of this process — from electrode design to signal interpretation to surgical decision-making — provides essential clinical context that enriches both exam preparation and bedside practice.
Scalp EEG signals must travel through the brain's outer layers, the cerebrospinal fluid, the skull, and the scalp itself before reaching surface electrodes — a journey that attenuates amplitude by roughly 10- to 100-fold and blurs spatial resolution. A single scalp electrode samples electrical activity from roughly 6 to 10 square centimeters of cortex, meaning small or deep seizure foci can be completely invisible on a standard EEG test. Muscle artifact, eye movement, and environmental electrical noise further degrade signal quality in many patients.
Invasive electrodes in direct contact with or embedded within brain tissue record signals that are orders of magnitude larger, cleaner, and more spatially precise. SEEG depth electrodes sample tissue within approximately 1 to 3 millimeters of each contact, while subdural grids resolve activity at 1-centimeter intervals across the cortical surface. This precision allows clinicians to identify the exact gyrus — sometimes even the specific cortical column — where seizures originate, enabling surgical resections targeted with an accuracy impossible to achieve with scalp-based monitoring alone.
A routine outpatient EEG test is one of the most patient-friendly diagnostic procedures in medicine: electrodes are applied with conductive paste or a cap, the test takes 20 to 40 minutes, and the patient returns home the same day with no aftereffects beyond slightly sticky hair. Many patients are surprised by how comfortable and anticlimactic the standard EEG test is, having expected something far more intimidating based on the equipment involved. EEG test side effects at this level are essentially limited to minor scalp irritation from the electrode paste.
Invasive EEG represents the opposite end of the spectrum. Patients undergo one or two neurosurgical procedures under general anesthesia, spend one to three weeks in the hospital with electrodes implanted in or on their brain, have their seizure medications intentionally reduced to provoke seizures, and must adapt to the physical and psychological demands of being continuously monitored in a hospital room. While modern epilepsy monitoring units are designed to be as comfortable as possible — with televisions, family visitation, and dedicated nursing support — the experience is demanding and requires thorough preparation and strong family support systems.
The EEG test price for a routine outpatient study ranges from approximately $200 to $700 for the technical component, with interpretation fees adding $100 to $300 more. Total out-of-pocket EEG test cost depends heavily on insurance coverage and whether the facility is in-network; most commercial insurance plans and Medicare cover medically necessary EEG testing with standard copays and deductibles applying. Ambulatory EEG monitoring, which records for 24 to 72 hours at home, typically costs $500 to $2,000 total depending on duration and provider.
Invasive EEG costs are in an entirely different category, typically running $50,000 to $150,000 or more when all components are included — the implantation surgery, the inpatient monitoring stay, electrode removal, and the resection surgery itself. However, commercial insurers, Medicare, and Medicaid generally cover invasive EEG when it is part of a documented pre-surgical epilepsy evaluation for patients who have failed at least two appropriately chosen anti-seizure medications. Patients should obtain prior authorization and work with their epilepsy center's financial counselors to understand their anticipated out-of-pocket obligations before proceeding.
Over the past decade, stereoelectroencephalography (SEEG) has become the dominant invasive EEG method at high-volume US epilepsy surgery centers, largely replacing open craniotomy-based subdural grid monitoring. The shift reflects SEEG's ability to sample bilateral and deep brain structures through minimally invasive drill holes, its lower hemorrhagic complication rate, and the widespread adoption of robotic stereotactic implantation systems. For EEG technologists, understanding SEEG electrode nomenclature, contact labeling conventions, and the unique artifact patterns of depth electrodes is increasingly essential to clinical practice and board exam success.
The risks associated with invasive EEG monitoring are real and must be discussed candidly with every patient before proceeding. Surgical complications fall into several categories: bleeding, infection, neurological deficits, and device-related problems. Symptomatic intracranial hemorrhage — bleeding around or within the brain — occurs in approximately 1 to 2 percent of SEEG implantations and 2 to 4 percent of subdural grid procedures.
Most bleeds are small and self-limiting, but a minority require surgical evacuation and, in rare cases, can result in permanent neurological deficits. The bleeding risk is why electrode trajectory planning goes to such lengths to avoid cortical veins and deep venous structures.
Infection is the second major concern. With foreign material implanted inside the skull for one to three weeks, the risk of meningitis or local wound infection is estimated at 1 to 3 percent across large published series. All patients receive prophylactic intravenous antibiotics at the time of implantation and throughout the monitoring period, and electrode exit sites are inspected daily for signs of redness, drainage, or tenderness. Fever during the monitoring period always prompts urgent evaluation, including cerebrospinal fluid analysis if meningitis is suspected.
EEG test side effects specific to the monitoring period itself — beyond the surgical risks — include headache from the implanted hardware, scalp discomfort at electrode exit sites, sleep disruption from nursing checks and monitoring alarms, and the psychological stress of being hospitalized and intentionally having seizures induced by medication reduction. Many patients also experience anxiety related to uncertainty about what the monitoring will reveal and whether they will ultimately be deemed surgical candidates. Psychological support and clear communication from the epilepsy team are essential throughout this period.
Neurological deficits from electrode placement are uncommon but possible, particularly when electrodes pass through or near functionally important cortex. Transient deficits — such as mild weakness, language difficulty, or visual changes — occur in perhaps 1 to 2 percent of patients and usually resolve within days to weeks as swelling subsides. Permanent deficits from electrode placement alone are rare, estimated at less than 0.5 percent in most published series, though this risk increases when electrodes are placed in eloquent regions specifically to map their boundaries before resection.
The risk of status epilepticus — prolonged or clustered seizures requiring emergency intervention — is an important consideration during the medication taper phase of monitoring. The epilepsy monitoring unit is specifically designed to manage this risk: nursing staff are trained in seizure first aid, medications for acute seizure management are immediately available at the bedside, and protocols for rapidly restoring anti-seizure medications exist at every center. Despite these precautions, roughly 5 to 10 percent of patients experience a seizure cluster or prolonged event requiring intervention during the monitoring period.
Long-term risks following the monitoring period itself are generally low. The implantation sites heal reliably in most patients, with most resolving within 4 to 6 weeks of electrode removal. SEEG drill holes are small enough that they typically do not require any additional closure beyond standard scalp wound care. Patients who proceed to craniotomy for resection after grid monitoring face additional surgical risks related to that definitive procedure, which are separate from the risks of the monitoring itself and should be discussed in detail with the neurosurgical team.
For EEG professionals and students studying for board certification, understanding the risk profile of invasive EEG is important not only for clinical practice but also for the ABRET R.EEG.T. and CLTM examinations, which test knowledge of electrode placement techniques, signal interpretation in the invasive setting, patient safety protocols, and the role of the EEG technologist in the epilepsy monitoring unit. Candidates should be comfortable with the distinction between SEEG and subdural monitoring, the types of complications that can occur, and the safety monitoring responsibilities of the EEG team during invasive recording.
Epilepsy surgery guided by invasive EEG produces some of the most transformative outcomes in all of neurology. In carefully selected patients with drug-resistant focal epilepsy, temporal lobe resection achieves seizure freedom — defined as complete absence of disabling seizures — in approximately 60 to 70 percent of patients at one year, with meaningful seizure reduction in an additional 15 to 20 percent. Extra-temporal resections guided by invasive EEG achieve somewhat lower but still clinically meaningful seizure-freedom rates of 40 to 60 percent, depending on the precision of localization and the completeness of the resection.
The quality-of-life impact of surgical seizure freedom is profound. Multiple large studies have documented improvements in employment rates, driving privileges, independence in daily activities, depression and anxiety scores, and overall life satisfaction following successful epilepsy surgery. A landmark randomized controlled trial published in the New England Journal of Medicine found that surgery was superior to continued medical management for temporal lobe epilepsy, with dramatically higher seizure-freedom rates and better quality-of-life outcomes in the surgical group at two-year follow-up. These findings underscore why the investment in invasive EEG — despite its costs and risks — is justified for appropriate candidates.
Outcomes are closely tied to the precision of pre-surgical localization. Patients whose invasive EEG clearly identifies a discrete, surgically accessible seizure-onset zone that is concordant with structural MRI findings achieve the highest rates of seizure freedom.
Conversely, patients with widespread or poorly localized onset zones, seizure-onset zones overlapping eloquent cortex, or discordant data across multiple diagnostic studies face more complex surgical decisions and somewhat lower expected outcomes. This is why the multidisciplinary conference review of invasive EEG data is so carefully conducted — there is rarely a simple answer, and the team's collective expertise shapes the recommendation for or against surgery.
Novel technologies are expanding the capabilities of invasive EEG and improving surgical outcomes. High-frequency oscillation analysis — detection of rapid brain waves in the 80 to 500 Hz range that mark the most epileptogenic tissue — is being integrated into clinical invasive EEG practice at leading centers, offering the potential to further refine resection boundaries. Responsive neurostimulation (RNS), a closed-loop brain stimulator that delivers electrical pulses when seizure activity is detected, relies on chronically implanted depth or cortical strip electrodes that function similarly to invasive EEG electrodes and provide years of continuous intracranial monitoring data post-implantation.
For patients who are not candidates for resective surgery — because the seizure focus overlaps with essential cortex or cannot be precisely localized — invasive EEG data can still guide other treatment options. Laser interstitial thermal therapy (LITT), a minimally invasive ablation technique, can be targeted to deep structures identified by SEEG with remarkable precision. Neuromodulation approaches including deep brain stimulation and RNS use invasive EEG findings to guide electrode placement for maximum therapeutic effect. In this sense, invasive EEG is not only a diagnostic tool but a therapeutic roadmap for the full spectrum of advanced epilepsy treatments.
For EEG technologists working in epilepsy monitoring units, the post-surgical period following electrode removal offers important learning opportunities. Reviewing pre- and post-surgical recordings side by side illustrates how seizure patterns change — or disappear entirely — after successful resection, reinforcing the clinical significance of every recording detail captured during the invasive monitoring phase. Understanding how to recognize post-surgical EEG changes, including expected asymmetries and focal slowing over the resection site, is a practical skill that distinguishes experienced epilepsy monitoring unit technologists from those newer to the specialty.
The relationship between invasive eeg and surgical decision-making represents the pinnacle of clinical neurophysiology — a place where the technical precision of signal recording directly shapes life-altering treatment decisions. For patients, the path through invasive monitoring can be difficult, but for those who achieve seizure freedom on the other side, the months of evaluation, surgery, and hospital monitoring often feel like a small price for a life no longer dominated by unpredictable seizures. For EEG professionals, mastering the clinical and technical dimensions of invasive monitoring opens opportunities at the highest levels of epilepsy care.
Whether you are a patient navigating the path toward invasive EEG or an EEG professional building expertise for board certification, a few practical strategies will help you engage with this complex topic more effectively. For patients, the single most important step is to seek evaluation at a comprehensive epilepsy center — a facility that performs at least 50 surgeries per year and has a full multidisciplinary team.
Volume matters: centers with greater surgical experience consistently report better outcomes and lower complication rates than lower-volume programs, and the expertise of the epileptologist, neurosurgeon, and EEG team directly determines the quality of the invasive monitoring data.
Ask your epileptologist specifically whether your center primarily uses SEEG or subdural grids, and understand the rationale for their recommendation in your specific case. Neither approach is universally superior — the choice depends on the hypothesized location of your seizure focus, your brain anatomy, and the specific clinical questions the team needs to answer. If you have any doubts about the recommended approach, seeking a second opinion at another comprehensive epilepsy center is entirely appropriate and routinely supported by epilepsy specialists, who understand the complexity and stakes of the surgical evaluation process.
During the monitoring period itself, patients can actively contribute to data quality by pressing the seizure detection button immediately when they feel an aura or warning sign — this creates a time-stamped marker in the recording that helps the EEG team identify seizure onset with precision. Keeping a detailed seizure diary throughout the pre-surgical evaluation period, noting the time, duration, and character of every seizure, provides valuable context for interpreting the invasive EEG findings. Any change in your typical seizure pattern during the monitoring period should be reported to the nursing staff immediately.
For EEG technologists and students preparing for the ABRET R.EEG.T. examination, invasive EEG is covered in the electrode placement, recording techniques, and clinical applications sections of the exam blueprint. Focus your study on understanding the difference between subdural and depth electrode recording characteristics, recognizing common artifact patterns in invasive recordings (including pulse artifact in depth electrodes near vessels), and understanding the role of the EEG technologist in high-frequency oscillation detection and cortical stimulation mapping protocols.
The CLTM (Certified Long-Term Monitoring) examination specifically emphasizes epilepsy monitoring unit practice, making invasive EEG knowledge even more central to exam success. CLTM candidates should be comfortable with electrode implantation nomenclature, the clinical significance of ictal onset patterns recorded invasively, safety protocols during medication tapering, and the documentation requirements for invasive monitoring studies. Review published guidelines from the American Clinical Neurophysiology Society (ACNS) on EMU practice and long-term monitoring, which form the evidence base for examination content.
Review of actual invasive EEG cases — either through published case series, educational atlases, or online resources offered by professional societies — is one of the most effective ways to build pattern recognition for board examination. Pay particular attention to examples of clear focal ictal onset with rapid spread, bitemporal independent onset (which often indicates poor surgical candidacy), and the appearance of high-frequency oscillations on intracranial recordings. These are the clinically significant patterns most likely to appear in examination vignettes.
Finally, remember that the EEG test — in all its forms, from the routine 20-minute outpatient study to the three-week invasive monitoring hospitalization — is fundamentally a window into the electrical life of the human brain. The sophistication of invasive EEG reflects how much detail that window can provide when pushed to its technical limits.
For patients, it represents a final opportunity to localize the source of disabling seizures and potentially achieve freedom from them. For EEG professionals, it represents the most demanding and rewarding application of their technical and clinical expertise. Investing time in understanding invasive EEG deeply — its methodology, its interpretation, its risks, and its outcomes — pays dividends both in clinical practice and in professional certification.